Stay updated on Abatacept Post-marketing Clinical Trial in Japan
Sign up to get notified when there's something new on the Abatacept Post-marketing Clinical Trial in Japan page.

Latest updates to the Abatacept Post-marketing Clinical Trial in Japan page
- Check4 days agoChange DetectedVersion updated to v3.0.2; removed the MedlinePlus Genetics topic 'Rheumatoid arthritis' and the 'Back to Top' link, and the previous v3.0.1 reference is gone.SummaryDifference0.6%
- Check11 days agoChange DetectedThe web page has been updated to include information on Rheumatoid arthritis under MedlinePlus Genetics topics, and the version has been revised from v3.0.0 to v3.0.1.SummaryDifference0.6%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of various facility names and locations in Japan, while also removing several previously listed locations and related medical topics. The revision number has been updated from v2.16.12 to v3.0.0.SummaryDifference9%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to Abatacept Post-marketing Clinical Trial in Japan
Enter your email address, and we'll notify you when there's something new on the Abatacept Post-marketing Clinical Trial in Japan page.